Percutaneous vena cava superior angioplasty and stenting as an effective method of treatment in vena cava superior syndrome in the course of lung cancer

• Authors: Szymon Darocha , Sebastian Szmit , Radosław Pietura , Marcin Kurzyna
• Languages of publication: EN

Abstracts

EN

Vena cava superior syndrome (VCSS) is a sudden life-threatening condition encountered in patients with neoplasms. The prognosis depends on histopathological diagnosis, severity of clinical symptoms and administered treatment. Depending on the type of neoplasm, the treatment of choice may be radiotherapy or chemotherapy. In patients with rapidly increasing clinical symptoms the justified management is percutaneous balloon angioplasty of the superior vena cava with the placement of stents.

Keywords

EN

lung cancer; vena cava superior stenting; vena cava superior syndrome

Discipline

• MEDICINE: MEDICINE

• Publisher: Medical Education
• Journal: OncoReview
• Year: 2014
• Volume: 4
• Issue: 3
• Pages: A108-112

Contributors

author

Szymon Darocha

• Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, European Health Centre Otwock, Poland

author

Sebastian Szmit

• Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, European Health Centre Otwock, Poland

author

Radosław Pietura

• Department of Radiography, Medical University of Lublin, Poland

author

Marcin Kurzyna

• Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, European Health Centre Otwock, Poland

References

• Escalante CP. Causes and management of superior vena cava syndrome. Oncology 1993; 7: 61-8.
• Ganeshan A, Hon LQ, Warakaulle DR et al. Superior vena caval stenting for SVC obstruction: current status. Eur J Radiol 2009; 71(2): 343-9.
• Kowalski DM, Krzakowski M. Zespół żyły głównej górnej – rozpoznawanie i leczenie. In: Postępowanie w powikłaniach sercowo-naczyniowych w raku płuca. Rekomendacje Krajowego Nadzoru Kardiologicznego i Onkologicznego dotyczące bezpieczeństwa kardiologicznego u chorych na raka płuca. Krzakowski M, Opolski G, Szmit S (ed.). Medical Education, Warszawa 2012: 21-29.
• You JB, Wilson LD, Detterbeck FC. Superior vena cava syndrome – a proposed classification system and algorithm for management. J Thorac Oncol 2008; 3: 811-814.
• Wilson LD, Detterbeck FC, Yahalom J. Superior vena cava syndrome with malignant causes. N Engl J Med 2007; 356: 1862-1869.
• Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. Cochrane Database Syst Rev 2001(4): CD001316.
• Sobrinho G, Aguiar P. Stent placement for the treatment of malignant superior vena cava syndrome – a single-center series of 56 patients. Arch Bronconeumol 2014; 50(4): 135-40.

• Document Type: report